🇺🇸 FDA
Patent

US 10039775

Preparation method for antitumor drug AP26113

granted A61KA61K31/675

Quick answer

US patent 10039775 (Preparation method for antitumor drug AP26113) held by Suzhou Miracpharma Technology Co., Ltd. expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Suzhou Miracpharma Technology Co., Ltd.
Grant date
Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/675